PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024
New York, N.Y., March 25, 2024 – PRISM MarketView – Drug development is an arduous, costly and time-consuming process for the teams involved behind the
New York, N.Y., March 25, 2024 – PRISM MarketView – Drug development is an arduous, costly and time-consuming process for the teams involved behind the
Conference Call on Thursday, March 28th at 12:00 pm ET / 9:00 am PT SAN FRANCISCO, CA, March 22, 2024 – American Shared Hospital Services
Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March
Conference Call on Monday, April 1st, at 4:30 pm ET POMPANO BEACH, FLORIDA, March 21, 2024 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative
Cheyenne, WY, March 21, 2024 – TransGlobal Assets Inc. (OTC: TMSH) is excited to announce a significant milestone as its wholly owned subsidiary, Better Health
LAS VEGAS, NEVADA, March 20, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in developing
LOS ANGELES, March 20, 2024 – Clubhouse Media Group, Inc., (OTC: CMGR) (“CMGR”), a social media firm, today announced that HoneyDrip.com will soon be adding
MIAMI, FL, March 18, 2024 – SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a highly disruptive platform technology company with over 77 pending and
New York, N.Y., March 18, 2024 – PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval
Las Vegas, NV, March 18, 2024 – PRISM MediaWire – Auto Parts 4 Less Group, Inc. (OTC: FLES) (“Auto Parts4Less,” “the Company”), a technology-driven e-commerce
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850